Loading...
Understanding and learning from the success of prophylactic human papillomavirus vaccines
An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections, and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the two most oncogenic virus types, HPV16 and HPV18, are now commercially available. In controlled clinical trials, the vaccine...
Na minha lista:
| Udgivet i: | Nat Rev Microbiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309166/ https://ncbi.nlm.nih.gov/pubmed/22961341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrmicro2872 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|